Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Paul Bisaro

At a glance: Paul Bisaro is Director at Myriad Genetics (MYGN). Their latest SEC Form 4, filed May 14, 2026, reported a purchase of $28K. On file: 2 purchase lines ($179K) and 0 sale lines ($0).

Disclosed holdings: about $543K of MYGN stock: 97,441 shares reported on their latest Form 4 (filed May 14, 2026), valued at the Nov 19, 2026 close of $5.58. This counts only MYGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Myriad Genetics Inc (MYGN); Director at Zoetis Inc. (ZTS)

Purchase track record

Below average. Based on 2 purchases with a full 90 days of price history.

37
Avg. 90-day return-4.4%
vs. S&P 500-8.1%
Beat the market0%
Paper profit on buys+$27K
Total bought / sold$179K / $0

Paul Bisaro's InsiderPrint

5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Paul Bisaro: 5 trades, 2020 to 20262020: 1 buy, 0 sales2021: 1 buy, 0 sales2022: 0 buys, 0 sales2023: 1 buy, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 2 buys, 0 sales

Reading this print: Almost only buys, trading about once a year, typically $42K a trade; often buys after the stock has fallen 15% or more.

  • Bump outward: a purchase (5)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Katharine WeymouthDirector · RSG · 99% matchTheir buys since 2021: 3 of 4 beat the S&P 500
  2. Gregory L. WeaverCFO · ALT · 99% matchTheir buys since 2023: 1 of 4 beat the S&P 500
  3. Peter Francis MinanCFO, President · NVRI · 98% match
  4. Amy W. SchulmanDirector · ALNY · 98% match
  5. Vickie L. CappsDirector · OFIX · 98% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
May 14SEC MYGNMyriad Genetics IncFirst buy Buy 7,50097,441 held (+8%) $3.69 $28K +51.1%
May 13SEC ZTSZoetis Inc.First buy Buy 2,00027,862 held (+8%) $75.88 $152K +8.4%
  • Buy

    Director Paul Bisaro bought $28K of MYGN at $3.69 — first open-market purchase in our records.

  • Buy

    Director Paul Bisaro bought $152K of ZTS at $75.88 — first open-market purchase in our records.

Follow Paul Bisaro

Get one email when Paul Bisaro files a new purchase or sale. Free.

At most one email a day about Paul Bisaro, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.